Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Optinose Inc (NQ: OPTN )

0.4800 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Optinose Inc

< Previous 1 2 3 4 5 Next >
Optinose Reports Third Quarter 2024 Financial Results and Recent Operational Highlights
From Optinose, Inc.
Via GlobeNewswire
Earnings Scheduled For November 12, 2024
Via Benzinga
Insights Ahead: OptiNose's Quarterly Earnings
Via Benzinga
Optinose Announces Reporting Date for Third Quarter 2024 Financial Results
Conference Call and Webcast to be held November 12, 2024, at 8:00 a.m. Eastern Time 
From Optinose, Inc.
Via GlobeNewswire
Optinose Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Optinose, Inc.
Via GlobeNewswire
Optinose Appoints Terry Kohler as Chief Financial Officer
From Optinose, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
New Peer-Reviewed Data Highlight the Benefits of XHANCE in Chronic Rhinosinusitis Patients with or without Prior Sinus Surgery
From Optinose, Inc.
Via GlobeNewswire
Optinose to Present at the H.C. Wainwright 26th Annual Global Investment Conference
From Optinose, Inc.
Via GlobeNewswire
OPTN Stock Earnings: OptiNose Beats EPS, Misses Revenue for Q2 2024
OPTN stock results show that OptiNose beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. 
Via InvestorPlace
Optinose Reports Second Quarter 2024 Financial Results and Recent Operational Highlights
From Optinose, Inc.
Via GlobeNewswire
Optinose Announces Reporting Date for Second Quarter 2024 Financial Results
Conference Call and Webcast to be held August 8, 2024, at 8:00 a.m. Eastern Time 
From Optinose, Inc.
Via GlobeNewswire
7 Little-Known Penny Stocks That Can Turn $10K Into $1 Million
Check out these explosive penny stocks with massive growth potential that could turn a modest $10,000 investment into a life-changing $1 million. 
Via InvestorPlace
Expanded Access to XHANCE with Addition to National Commercial Formularies
From Optinose, Inc.
Via GlobeNewswire
Optinose to Present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ
From Optinose, Inc.
Via GlobeNewswire
Why Doximity Shares Are Trading Higher By 14%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
OPTN Stock Earnings: OptiNose Misses EPS, Beats Revenue for Q1 2024
OPTN stock results show that OptiNose missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. 
Via InvestorPlace
Optinose Reports First Quarter 2024 Financial Results and Recent Operational Highlights
From Optinose, Inc.
Via GlobeNewswire
Optinose Announces Reporting Date for First Quarter 2024 Financial Results
Conference Call and Webcast to be held May 14, 2024, at 10:00 a.m. Eastern Time 
From Optinose, Inc.
Via GlobeNewswire
Optinose Announces $55 Million Registered Direct Offering
From Optinose, Inc.
Via GlobeNewswire
Bristol-Myers Squibb Layoffs 2024: What to Know About the Latest BMY Job Cuts
Bristol-Myers Squibb layoffs will see the company reduce its headcount by 6% as part of an effort to reduce expenses in 2024. 
Via InvestorPlace
Topics Workforce
Exposures Layoff
Why Are Stocks Down Today?
Stocks are down today and investors wondering why have come to the right place as we have all the news on the market drop on Thursday. 
Via InvestorPlace
Why Caterpillar Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Why Is OptiNose (OPTN) Stock Up 12% Today?
OptiNose stock is taking off on Thursday alongside an update on XHANCE that brings heavy trading to OPTN shares this morning. 
Via InvestorPlace
Optinose Provides Corporate Update on XHANCE Launch and Outlook and Announces Preliminary First Quarter 2024 XHANCE Net Revenue of $14.9 million
Conference Call and Webcast to be held April 25, 2024, at 10:00 a.m. Eastern Time 
From Optinose, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Optinose to Present at the Needham Virtual Healthcare Conference
From Optinose, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
XHANCE Approved by FDA as First and Only Medication Indicated for Treatment of Adults with Chronic Rhinosinusitis without Nasal Polyps
From Optinose, Inc.
Via GlobeNewswire
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.